[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Natural Killer Cells Therapeutics Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

September 2023 | 125 pages | ID: G45D7FB92DD7EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question


The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Natural Killer Cells Therapeutics market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Natural Killer Cells Therapeutics market are covered in Chapter 9:

Celgene Corporation
Glycostem
Celularity
Affimed
Fate Therapeutics
NantKwest
NKT Therapeutics Inc.
Cyto-Sen Therapeutics
Fortress Biotech Inc.
Innate Pharma S.A
Nkarta Therapeutics
Cytovac
Ziopharm Oncology, Inc.

In Chapter 5 and Chapter 7.3, based on types, the Natural Killer Cells Therapeutics market from 2017 to 2027 is primarily split into:

NK Cell Therapies
NK Cell Directed Antibodies


In Chapter 6 and Chapter 7.4, based on applications, the Natural Killer Cells Therapeutics market from 2017 to 2027 covers:

Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Natural Killer Cells Therapeutics market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Natural Killer Cells Therapeutics Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027

1 NATURAL KILLER CELLS THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Natural Killer Cells Therapeutics Market
1.2 Natural Killer Cells Therapeutics Market Segment by Type
  1.2.1 Global Natural Killer Cells Therapeutics Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Natural Killer Cells Therapeutics Market Segment by Application
  1.3.1 Natural Killer Cells Therapeutics Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Natural Killer Cells Therapeutics Market, Region Wise (2017-2027)
  1.4.1 Global Natural Killer Cells Therapeutics Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
  1.4.3 Europe Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
  1.4.4 China Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
  1.4.5 Japan Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
  1.4.6 India Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
  1.4.8 Latin America Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Natural Killer Cells Therapeutics Market Status and Prospect (2017-2027)
1.5 Global Market Size of Natural Killer Cells Therapeutics (2017-2027)
  1.5.1 Global Natural Killer Cells Therapeutics Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Natural Killer Cells Therapeutics Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Natural Killer Cells Therapeutics Market

2 INDUSTRY OUTLOOK

2.1 Natural Killer Cells Therapeutics Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Natural Killer Cells Therapeutics Market Drivers Analysis
2.4 Natural Killer Cells Therapeutics Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Natural Killer Cells Therapeutics Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Natural Killer Cells Therapeutics Industry Development

3 GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET LANDSCAPE BY PLAYER

3.1 Global Natural Killer Cells Therapeutics Sales Volume and Share by Player (2017-2022)
3.2 Global Natural Killer Cells Therapeutics Revenue and Market Share by Player (2017-2022)
3.3 Global Natural Killer Cells Therapeutics Average Price by Player (2017-2022)
3.4 Global Natural Killer Cells Therapeutics Gross Margin by Player (2017-2022)
3.5 Natural Killer Cells Therapeutics Market Competitive Situation and Trends
  3.5.1 Natural Killer Cells Therapeutics Market Concentration Rate
  3.5.2 Natural Killer Cells Therapeutics Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL NATURAL KILLER CELLS THERAPEUTICS SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Natural Killer Cells Therapeutics Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Natural Killer Cells Therapeutics Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Natural Killer Cells Therapeutics Market Under COVID-19
4.5 Europe Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Natural Killer Cells Therapeutics Market Under COVID-19
4.6 China Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Natural Killer Cells Therapeutics Market Under COVID-19
4.7 Japan Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Natural Killer Cells Therapeutics Market Under COVID-19
4.8 India Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Natural Killer Cells Therapeutics Market Under COVID-19
4.9 Southeast Asia Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Natural Killer Cells Therapeutics Market Under COVID-19
4.10 Latin America Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Natural Killer Cells Therapeutics Market Under COVID-19
4.11 Middle East and Africa Natural Killer Cells Therapeutics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Natural Killer Cells Therapeutics Market Under COVID-19

5 GLOBAL NATURAL KILLER CELLS THERAPEUTICS SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Natural Killer Cells Therapeutics Sales Volume and Market Share by Type (2017-2022)
5.2 Global Natural Killer Cells Therapeutics Revenue and Market Share by Type (2017-2022)
5.3 Global Natural Killer Cells Therapeutics Price by Type (2017-2022)
5.4 Global Natural Killer Cells Therapeutics Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Natural Killer Cells Therapeutics Sales Volume, Revenue and Growth Rate of NK Cell Therapies (2017-2022)
  5.4.2 Global Natural Killer Cells Therapeutics Sales Volume, Revenue and Growth Rate of NK Cell Directed Antibodies (2017-2022)

6 GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6.1 Global Natural Killer Cells Therapeutics Consumption and Market Share by Application (2017-2022)
6.2 Global Natural Killer Cells Therapeutics Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Natural Killer Cells Therapeutics Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Cancer (2017-2022)
  6.3.2 Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Gastrointestinal Diseases (2017-2022)
  6.3.3 Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Immunoproliferative Disorders (2017-2022)

7 GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET FORECAST (2022-2027)

7.1 Global Natural Killer Cells Therapeutics Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Natural Killer Cells Therapeutics Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Natural Killer Cells Therapeutics Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Natural Killer Cells Therapeutics Price and Trend Forecast (2022-2027)
7.2 Global Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Natural Killer Cells Therapeutics Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Natural Killer Cells Therapeutics Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Natural Killer Cells Therapeutics Revenue and Growth Rate of NK Cell Therapies (2022-2027)
  7.3.2 Global Natural Killer Cells Therapeutics Revenue and Growth Rate of NK Cell Directed Antibodies (2022-2027)
7.4 Global Natural Killer Cells Therapeutics Consumption Forecast by Application (2022-2027)
  7.4.1 Global Natural Killer Cells Therapeutics Consumption Value and Growth Rate of Cancer(2022-2027)
  7.4.2 Global Natural Killer Cells Therapeutics Consumption Value and Growth Rate of Gastrointestinal Diseases(2022-2027)
  7.4.3 Global Natural Killer Cells Therapeutics Consumption Value and Growth Rate of Immunoproliferative Disorders(2022-2027)
7.5 Natural Killer Cells Therapeutics Market Forecast Under COVID-19

8 NATURAL KILLER CELLS THERAPEUTICS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Natural Killer Cells Therapeutics Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Natural Killer Cells Therapeutics Analysis
8.6 Major Downstream Buyers of Natural Killer Cells Therapeutics Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Natural Killer Cells Therapeutics Industry

9 PLAYERS PROFILES

9.1 Celgene Corporation
  9.1.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.1.3 Celgene Corporation Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Glycostem
  9.2.1 Glycostem Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.2.3 Glycostem Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Celularity
  9.3.1 Celularity Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.3.3 Celularity Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Affimed
  9.4.1 Affimed Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.4.3 Affimed Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Fate Therapeutics
  9.5.1 Fate Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.5.3 Fate Therapeutics Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 NantKwest
  9.6.1 NantKwest Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.6.3 NantKwest Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 NKT Therapeutics Inc.
  9.7.1 NKT Therapeutics Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.7.3 NKT Therapeutics Inc. Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Cyto-Sen Therapeutics
  9.8.1 Cyto-Sen Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.8.3 Cyto-Sen Therapeutics Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Fortress Biotech Inc.
  9.9.1 Fortress Biotech Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.9.3 Fortress Biotech Inc. Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Innate Pharma S.A
  9.10.1 Innate Pharma S.A Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.10.3 Innate Pharma S.A Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Nkarta Therapeutics
  9.11.1 Nkarta Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.11.3 Nkarta Therapeutics Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Cytovac
  9.12.1 Cytovac Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.12.3 Cytovac Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 Ziopharm Oncology, Inc.
  9.13.1 Ziopharm Oncology, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Natural Killer Cells Therapeutics Product Profiles, Application and Specification
  9.13.3 Ziopharm Oncology, Inc. Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Natural Killer Cells Therapeutics Product Picture
Table Global Natural Killer Cells Therapeutics Market Sales Volume and CAGR (%) Comparison by Type
Table Natural Killer Cells Therapeutics Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Natural Killer Cells Therapeutics Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Natural Killer Cells Therapeutics Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Natural Killer Cells Therapeutics Industry Development
Table Global Natural Killer Cells Therapeutics Sales Volume by Player (2017-2022)
Table Global Natural Killer Cells Therapeutics Sales Volume Share by Player (2017-2022)
Figure Global Natural Killer Cells Therapeutics Sales Volume Share by Player in 2021
Table Natural Killer Cells Therapeutics Revenue (Million USD) by Player (2017-2022)
Table Natural Killer Cells Therapeutics Revenue Market Share by Player (2017-2022)
Table Natural Killer Cells Therapeutics Price by Player (2017-2022)
Table Natural Killer Cells Therapeutics Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Natural Killer Cells Therapeutics Sales Volume, Region Wise (2017-2022)
Table Global Natural Killer Cells Therapeutics Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Natural Killer Cells Therapeutics Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Natural Killer Cells Therapeutics Sales Volume Market Share, Region Wise in 2021
Table Global Natural Killer Cells Therapeutics Revenue (Million USD), Region Wise (2017-2022)
Table Global Natural Killer Cells Therapeutics Revenue Market Share, Region Wise (2017-2022)
Figure Global Natural Killer Cells Therapeutics Revenue Market Share, Region Wise (2017-2022)
Figure Global Natural Killer Cells Therapeutics Revenue Market Share, Region Wise in 2021
Table Global Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Natural Killer Cells Therapeutics Sales Volume by Type (2017-2022)
Table Global Natural Killer Cells Therapeutics Sales Volume Market Share by Type (2017-2022)
Figure Global Natural Killer Cells Therapeutics Sales Volume Market Share by Type in 2021
Table Global Natural Killer Cells Therapeutics Revenue (Million USD) by Type (2017-2022)
Table Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2017-2022)
Figure Global Natural Killer Cells Therapeutics Revenue Market Share by Type in 2021
Table Natural Killer Cells Therapeutics Price by Type (2017-2022)
Figure Global Natural Killer Cells Therapeutics Sales Volume and Growth Rate of NK Cell Therapies (2017-2022)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate of NK Cell Therapies (2017-2022)
Figure Global Natural Killer Cells Therapeutics Sales Volume and Growth Rate of NK Cell Directed Antibodies (2017-2022)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate of NK Cell Directed Antibodies (2017-2022)
Table Global Natural Killer Cells Therapeutics Consumption by Application (2017-2022)
Table Global Natural Killer Cells Therapeutics Consumption Market Share by Application (2017-2022)
Table Global Natural Killer Cells Therapeutics Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Natural Killer Cells Therapeutics Consumption Revenue Market Share by Application (2017-2022)
Table Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Cancer (2017-2022)
Table Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Gastrointestinal Diseases (2017-2022)
Table Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Immunoproliferative Disorders (2017-2022)
Figure Global Natural Killer Cells Therapeutics Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Natural Killer Cells Therapeutics Price and Trend Forecast (2022-2027)
Figure USA Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Natural Killer Cells Therapeutics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Natural Killer Cells Therapeutics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Natural Killer Cells Therapeutics Market Sales Volume Forecast, by Type
Table Global Natural Killer Cells Therapeutics Sales Volume Market Share Forecast, by Type
Table Global Natural Killer Cells Therapeutics Market Revenue (Million USD) Forecast, by Type
Table Global Natural Killer Cells Therapeutics Revenue Market Share Forecast, by Type
Table Global Natural Killer Cells Therapeutics Price Forecast, by Type
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate of NK Cell Therapies (2022-2027)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate of NK Cell Therapies (2022-2027)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate of NK Cell Directed Antibodies (2022-2027)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate of NK Cell Directed Antibodies (2022-2027)
Table Global Natural Killer Cells Therapeutics Market Consumption Forecast, by Application
Table Global Natural Killer Cells Therapeutics Consumption Market Share Forecast, by Application
Table Global Natural Killer Cells Therapeutics Market Revenue (Million USD) Forecast, by Application
Table Global Natural Killer Cells Therapeutics Revenue Market Share Forecast, by Application
Figure Global Natural Killer Cells Therapeutics Consumption Value (Million USD) and Growth Rate of Cancer (2022-2027)
Figure Global Natural Killer Cells Therapeutics Consumption Value (Million USD) and Growth Rate of Gastrointestinal Diseases (2022-2027)
Figure Global Natural Killer Cells Therapeutics Consumption Value (Million USD) and Growth Rate of Immunoproliferative Disorders (2022-2027)
Figure Natural Killer Cells Therapeutics Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Celgene Corporation Profile
Table Celgene Corporation Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Glycostem Profile
Table Glycostem Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Glycostem Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Glycostem Revenue (Million USD) Market Share 2017-2022
Table Celularity Profile
Table Celularity Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celularity Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Celularity Revenue (Million USD) Market Share 2017-2022
Table Affimed Profile
Table Affimed Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Affimed Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Affimed Revenue (Million USD) Market Share 2017-2022
Table Fate Therapeutics Profile
Table Fate Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Fate Therapeutics Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Fate Therapeutics Revenue (Million USD) Market Share 2017-2022
Table NantKwest Profile
Table NantKwest Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure NantKwest Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure NantKwest Revenue (Million USD) Market Share 2017-2022
Table NKT Therapeutics Inc. Profile
Table NKT Therapeutics Inc. Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure NKT Therapeutics Inc. Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure NKT Therapeutics Inc. Revenue (Million USD) Market Share 2017-2022
Table Cyto-Sen Therapeutics Profile
Table Cyto-Sen Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cyto-Sen Therapeutics Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Cyto-Sen Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Fortress Biotech Inc. Profile
Table Fortress Biotech Inc. Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Fortress Biotech Inc. Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Fortress Biotech Inc. Revenue (Million USD) Market Share 2017-2022
Table Innate Pharma S.A Profile
Table Innate Pharma S.A Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Innate Pharma S.A Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Innate Pharma S.A Revenue (Million USD) Market Share 2017-2022
Table Nkarta Therapeutics Profile
Table Nkarta Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nkarta Therapeutics Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Nkarta Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Cytovac Profile
Table Cytovac Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cytovac Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Cytovac Revenue (Million USD) Market Share 2017-2022
Table Ziopharm Oncology, Inc. Profile
Table Ziopharm Oncology, Inc. Natural Killer Cells Therapeutics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ziopharm Oncology, Inc. Natural Killer Cells Therapeutics Sales Volume and Growth Rate
Figure Ziopharm Oncology, Inc. Revenue (Million USD) Market Share 2017-2022


More Publications